Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-06-06
2006-06-06
Mertz, Prema (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S387900, C530S388100, C530S389100, C530S389200, C530S388230, C530S387300, C435S325000, C435S326000
Reexamination Certificate
active
07056681
ABSTRACT:
The present invention concerns a novel human cytokine. In particular, isolated nucleic acid molecules are provided encoding interleukin-19 (IL-19). IL-19 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The IL-19 polypeptides of the present invention can also be used to raise polyclonal and monoclonal antibodies. The invention further concerns therapeutic methods for modulating cytokine production.
REFERENCES:
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5985614 (1999-11-01), Rosen et al.
patent: 6583270 (2003-06-01), Rosen et al.
Skolnick et al. (Mar. 2000), Nature Biotechnology, vol. 18, pp. 283-287.
NCBI Entrez, GenBank Report, Accession No. M59456, from Maridor, G., et al. (1993).
NCBI Entrez, GenBank Report, Accession No. U16720, from Sanjanwala, B., and de Waal-Malefyt, R. (Oct. 1995).
Doerks, T., et al ., “Protein annotation: detective work for function prediction,”Trends Genet. 14:248-250, Elsevier Trends Journals (Jun. 1998).
Mikayama, T., et al., “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,”Proc. Natl. Acad. Sci. USA90:10056-10060, National Academy of Sciences (1993).
Voet, D., and Voet, J.G., eds., “Chemical Evolution and Abnormal Hemoglobins,” inBiochemistry, John Wiley & Sons, Inc., Hoboken, NJ, pp. 126-128 and 228-234 (1990).
U.S. Appl. No. 09/912,293, filed Jul. 26, 2001 (Not Published).
Baer, R. et al., “DNA sequence and expression of the B95-8 Epstein-Barr virus genome,”Nature310:207-211, Macmillan Publishers (1984).
Benjamin, D. et al., “Human B-Cell Interleukin-10: B-Cell Lines Derived From Patients With Acquired Immunodeficiency Syndrome and Burkitt's Lymphoma Constitutively Secrete Large Quantities of Interleukin-10,”Blood 80(5):1289-1298, American Society of Hematology (1992).
Bowie, J. U. et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science 247:1306-1310. American Association for the Advancement of Science (1990).
Clark-Lewis, I. et al., “Structural Requirements for Interleukin-8 Function Identified by Design of Analogs and CXC Chemokine Hybrids,”J. Biol. Chem. 269:16075-16081, American Society for Biochemistry and Molecular Biology (1994).
Cunningham, B.C. and Wells, J.A., “High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis,”Science 244:1081-1085, American Association for the Advancement of Science (1989).
de Waal Malefyt, R. et al., “Interleukin 10 (IL-10) and Viral IL-10 Strongly Reduce Antigen-specific Human T Cell Proliferation by Diminishing the Antigen-presenting Capacity of Monocytes via Downregulation of Class II Major Histocompatibility Complex Expression,”J. Exp. Med. 174(4):915-924, Rockefeller University Press (1991).
de Waal Malefyt, R. et al., “Interleukin 10 (IL-10) Inhibits Cytokine Synthesis by Human Monocytes. ”J. Exp. Med. 174(5):1209-1220, Rockefeller University Press (1991).
Feng, L. et al., “Molecular Cloning of Rat Cytokine Synthesis Inhibitory Factor (IL-10) cDNA and Expression in Spleen and Macrophages,”Biochem. Biophys. Res. Commun. 192(2):452-458, Academic Press (1993).
Fiorentino, D.F. et al., “Two Types of Mouse T Helper Cell, IV. Th2 Clones Secrete a Factor that Inhibits Cytokine Production by Th1 Clones,”J. Exp. Med. 170:2081-2095, Rockefeller University Press (1989).
Fiorentino, D.F. et al., “IL-10 Inhibits Cytokine Production by Activated Macrophages,”J. Immunol. 147(11):3815-3822, American Association of Immunologists (1991).
Gayle III, R.B. et al., “Identification of Regions in Interleukin-1α Important for Activity,”J. Biol. Chem. 268(29):22105-22111, American Society for Biochemistry and Molecular Biology (1993).
George, D.G. et al., “Current Methods in Sequence Comparison and Analysis,” inMacromolecular Sequencing and Synthesis, Selected Methods and Applications, Schlesinger, D.H., ed., Alan R. Liss, Inc., New York, NY, Chapter 12, pp. 127-149 (1988).
Gronenborn, A.M. et al., “Site directed mutants of human interleukin-1α: a1H-NMR and receptor binding study,”FEBS Lett.231(1) :135-138, Elsevier Science B.V. (1988).
Harlow, E. and Lane, D.,Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 76 (1988).
Hash, S.M. et al., “Characterization of a cDNA encoding bovine interleukin 10: kinetics of expression in bovine lymphocytes,”Gene 139:257-261, Elsevier/North-Holland (1994).
Hayakawa, K. and Hardy, R.R., “Normal Autoimmune, and Malignant CD5* B Cells: The Ly-1 B Lineage?”Ann. Rev. Immunol. 6:197-218, Annual Reviews (1998).
Heinz, D.W. et al., “Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence,”Proc. Natl. Acad. Sci. USA 89:3751-3755, National Academy of Sciences (1992).
Hellyer, N.J. et al., “Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein,”Gene 165:279-284, Elsevier/North-Holland (Nov. 1995).
Hisatsune, T. et al., “A Suppressive Lymphokine Derived from T5Clone 13G2 Is IL-10,”Lymphokine Cytokine Res.11(2):87-93, Mary Ann Liebert (1992).
Ishida, H. et al., “Continuous Anti-Interleukin 10 Antibody Administration Depletes Mice of Ly-1 B Cells but not Conventional B Cells,”J. Exp. Med. 175(5):1213-1220, Rockefeller University Press (1992).
Kruse, N. et al., “Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation,”EMBO J. 12(13):5121-5129, Oxford University Press (1993).
Larsen, G. R. et al., “Variants of Human Tissue-type Plasminogen Activator,”J. Biol. Chem. 263(2):1023-1029, American Society for Biochemistry and Molecular Biology (1988).
Lin, T.-Z. et al., “Cytokines in NZB CD5* B Clones,”Ann. N.Y. Acad. Sci. 651:581-583, New York Academy of Sciences (1992).
MacNeil, I.A. et al., “IL-10, a Novel Growth Cofactor for Mature and Immature T Cells,”J. Immunol. 145(12):4167-4173, American Association of Immunologists (1990).
Moore, K.W. et al., “Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI,”Science 248:1230-1234, American Association for the Advancement of Science (1990).
Moore, K.W. et al.,Science 250:494 (1990). Erratum to Moore, K.W. et al., “Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI,”Science 248:1230-1234, American Association for the Advancement of Science (1990).
Mosley, B. et al., “Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1α and 1β,”Proc. Natl. Acad. Sci. USA 84:4572-4576, National Academy of Science (1987).
O'Garra, A. et al., “Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10,”Int. Immunol. 2(9):821-832, Oxford University Press (1990).
Ralph, P. et al., “IL-10, T Lymphocyte Inhibitor of Human Blood Cell Production of IL-1 and Tumor Necrosis Factor,”J. Immunol. 148(3):808-814, American Association of Immunologists (1992).
Salgame, P. et al., “Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones,”Science 254:279-282, American Association for the Advancement of Science (1991).
Suda, T. et al., “Identification of a Novel Thymocyte Growth-Promoting Factor Derived from B Cell Lymphomas,”Cell. Immunol. 129:228-240, Academic Prss (1990).
Tartaglia, L.A. et al., “Identification and Expression Cloning of a Leptin Receptor, OB-R,”Cell 83:1263-1271, Cell Press (Dec. 1995).
Vieira, P. et al., “Isolation and expression of human cytokine synthesis in
Kenny Joseph J
Rosen Craig A
Human Genome Sciences Inc.
Mertz Prema
Sterne, Kessler, Goldstein & Fox P.L.L.C
LandOfFree
Interleukin-19 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-19 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-19 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3637747